Vaccine sales recover at GSK in Q3, but lockdown fears weigh on sharesGlaxoSmithKline saw a recovery in its vaccine sales in the third quarter after a big hit in the Share XVaccine sales recover at GSK in Q3, but lockdown fears weigh on shareshttps://pharmaphorum.com/news/vaccine-sales-recover-at-gsk-in-q3-but-lockdown-fears-weigh-on-shares/
Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shotRussia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see Share XRussia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shothttps://pharmaphorum.com/market-access-2/russias-sputnik-v-covid-19-shot-filed-with-who/
Moderna nears COVID-19 vaccine finish line as it wraps up study enrolmentModerna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of Share XModerna nears COVID-19 vaccine finish line as it wraps up study enrolmenthttps://pharmaphorum.com/news/moderna-nears-covid-19-vaccine-finish-line-as-it-wraps-up-study-enrolment/
AZ, J&J COVID-19 vaccine trials okay to restart in USUS trials of AstraZeneca’s experimental COVID-19 vaccine AZD1222 have been cleared to restart by the FDA, several weeks Share XAZ, J&J COVID-19 vaccine trials okay to restart in UShttps://pharmaphorum.com/news/az-jj-coronavirus-vaccine-trials-okay-to-restart-in-us/
Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedPfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at Share XPfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedhttps://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/
Sanofi preps trials of second COVID-19 shot, as Russia approves anotherSanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after Share XSanofi preps trials of second COVID-19 shot, as Russia approves anotherhttps://pharmaphorum.com/news/sanofi-preps-trials-of-second-covid-19-shot-as-russia-approves-another/
EU ramps up supply of COVID-19 vaccine, drugsThe European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after Share XEU ramps up supply of COVID-19 vaccine, drugshttps://pharmaphorum.com/news/eu-ramps-up-supply-of-covid-19-vaccine-drugs/
FDA gives COVID-19 vaccine ‘advice’ after White House blocks guidanceThe FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Share XFDA gives COVID-19 vaccine ‘advice’ after White House blocks guidancehttps://pharmaphorum.com/news/fda-gives-covid-19-vaccine-advice-after-white-house-blocks-guidance/
EMA review of AZ’s COVID-19 vaccine imminent; reportThe EU regulator is poised to start a review of AstraZeneca and Oxford University’s COVID-19 vaccine, but the Share XEMA review of AZ’s COVID-19 vaccine imminent; reporthttps://pharmaphorum.com/news/ema-review-of-azs-covid-19-vaccine-imminent-report/
